The importance of the measurement of circulating markers in patients with neuroendocrine tumours of the pancreas and gut.

@article{Ardill2003TheIO,
  title={The importance of the measurement of circulating markers in patients with neuroendocrine tumours of the pancreas and gut.},
  author={Joy E. S. Ardill and B Erikkson},
  journal={Endocrine-related cancer},
  year={2003},
  volume={10 4},
  pages={459-62}
}
The measurement of general and specific biochemical markers in patients with neuroendocrine tumours assists with diagnosis and gives an indication of the effectiveness of treatment and they may be used as prognostic indicators. There is much agreement that chromogranin A is the most universally helpful marker; it is found to be elevated in the circulation of about 90% of patients with metastatic neuroendocrine tumours and there are several excellent commercially available kits which give… CONTINUE READING
27 Citations
19 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 27 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 19 references

Clinical and biological prognostic indicators at diagnosis in 117 midgut carcinoid tumours

  • GB Turner, BT Johnston, DR McCance, Watson RGP, KD Buchanan, Ardill JES
  • Regulatory Peptides
  • 2002
2 Excerpts

Diagnostic value of plasma chromogranin A in neuroendocrine tumours

  • P Tomassetti, M Migiori, P Simoni, R Casadei, R De lasio, L Gullo
  • European Journal of Gastroenterology and…
  • 2001

Similar Papers

Loading similar papers…